Tori Rodriguez, MA, LPC, AHC

Joseph J. Jennings, MD, and Cynthia L. Sears, MD, describe the systemic effects of H pylori infection and clinical approaches for treating the extragastric complications.

In this Q&A, Drs Serota and Thakarar discuss the dual subspecialty of infectious disease and addiction medicine and its role in combating the ongoing opioid epidemic.

Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.

In a Q&A, Asher Schranz, MD, MPH, discusses the importance of physician collaboration in the treatment of patients with drug use-associated infective endocarditis.

Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.

About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.

A significant number of cases of post-COVID-19 myocarditis have been reported.

To discuss the potential factors driving the increasing alcohol use among women as well as potential solutions, we interviewed David Streem, MD, and Leena P. Mittal, MD, FACLP.

Recent studies have shown an increase in depression and suicidality in transgender youth. To learn more about the mental health challenges affecting transgender youth and how clinicians can better support these patients, we interviewed Jason V. Lambrese, MD, staff child and adolescent psychiatrist at Cleveland Clinic’s Lakewood Family Health Canter in Lakewood, Ohio, and Ralph Vetters, MD, MPH, pediatrician and site medical director at the Sidney Borum Jr. Health Center, a program of Fenway Health in Boston.

With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.